Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse methylprednisolone vs high-dose dexamethasone for moderate COVID-19 pneumonia
TCTR20211017001Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone, dexamethasone in coronavirus pneumonia, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on TCTR20211017001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211017001.